UNC-79 inhibitors are chemical compounds that target various signaling pathways and cellular processes to indirectly suppress the functional activity of UNC-79, a protein predominantly involved in neuronal signaling and regulation. These inhibitors include those that disrupt the phosphorylation landscape within neurons, either by activating or inhibiting protein kinase C (PKC), which is known to phosphorylate a plethora of substrates, thereby influencing the function of UNC-79. The aberrant phosphorylation states induced by these compounds lead to a cascade of changes in neuronal signaling that could impact the normal activity of UNC-79. Other inhibitors in this category act by blocking voltage-gated sodium channels, thereby reducing neuronal excitability and indirectly affecting the neuronal processes that UNC-79 is implicated in. Furthermore, agents that antagonize calmodulin or inhibit calcineurin interfere with calcium signaling within neurons, a critical process in which UNC-79 is involved, thereby leading to its functional inhibition.
Another group of UNC-79 inhibitors operates by perturbing intracellular trafficking, which is essential for neuronal function and survival. This is achieved by inhibiting enzymes such as vacuolar-type H+-ATPase (V-ATPase), which leads to the disruption of endosomal-lysosomal acidification, a pathway critical to the proper trafficking and sorting of cellular components where UNC-79 may play a role. Compounds that block L-type calcium channels also contribute to the inhibition of UNC-79 by altering calcium influx and subsequent signaling cascades. In addition, interference with the PI3K/AKT signaling pathway by specific kinase inhibitors can affect UNC-79's contribution to neuronal survival and function. There are also inhibitors that modulate cytoskeletal dynamics by targeting myosin light chain kinase, thereby potentially influencing UNC-79's involvement in neuronal development and signaling. Lastly, partial agonists of nicotinic acetylcholine receptors alter cholinergic signaling, which can have downstream effects on the neurological pathways that involve UNC-79, culminating in its inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
By activating protein kinase C (PKC), PMA modulates phosphorylation states of various proteins. UNC-79 function is likely altered by PKC-mediated phosphorylation changes due to its role in neuronal signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent PKC inhibitor that could alter UNC-79 function by preventing PKC-mediated phosphorylation events that are necessary for proper UNC-79 activity. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibitor of the vacuolar-type H+-ATPase (V-ATPase) which could disrupt endosomal-lysosomal acidification, indirectly affecting UNC-79's associated processes due to its role in intracellular trafficking. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist that could inhibit the calcium/calmodulin-dependent kinase, potentially affecting UNC-79's modulation of neuronal activity by altering downstream calcium signaling pathways. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Inhibits calcineurin, potentially altering phosphorylation states of proteins and indirectly affecting UNC-79’s role in synaptic function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
L-type calcium channel blocker that could indirectly inhibit UNC-79 by altering calcium influx and signaling cascades in neurons, where UNC-79 is functional. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
D2 dopamine receptor antagonist that could affect dopamine signaling pathways involved in motor control, potentially altering processes that UNC-79 is part of. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Inhibitor of V-ATPase, and therefore could also disrupt endosomal-lysosomal acidification, affecting UNC-79's function in intracellular trafficking. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
Inhibitor of myosin light chain kinase (MLCK), which could affect cytoskeletal dynamics and potentially alter UNC-79’s role in neuronal development and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that could disrupt AKT signaling, potentially affecting UNC-79’s role in neuronal survival and function. | ||||||